Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis.
about
Clinical significance of ERCC1, RRM1 and TS in non-small cell lung cancerPromising targets and current clinical trials in metastatic squamous cell lung cancerPemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression.Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer.Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.Prognostic significance of thymidylate synthase in postoperative non-small cell lung cancer patientsPemetrexed and cisplatin for the treatment of advanced, persistent, or recurrent carcinoma of the cervix: a limited access phase II trial of the gynecologic oncology group.Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10-17).Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterationsVariation in the expression levels of predictive chemotherapy biomarkers in histological subtypes of lung adenocarcinoma: an immunohistochemical study of tissue samplesTargeting Nonsquamous Nonsmall Cell Lung Cancer via the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]Pyrimidine Thienoyl Antifolates.The ERK-ZEB1 pathway mediates epithelial-mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids.Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.Farletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategy.Thymidylate Synthase as a Predictive Biomarker for Pemetrexed Response in NSCLC.Chemotherapy Resistance in Lung Cancer.Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape.Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expressionHigh pemetrexed sensitivity of docetaxel-resistant A549 cells is mediated by TP53 status and downregulated thymidylate synthase.Significance of glucocorticoid receptor expression in patients with non-small cell lung cancer treated with pemetrexed-based chemotherapy.Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung Cancer.Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.Utilizing radiolabeled 3'-deoxy-3'-[18F]fluorothymidine with positron emission tomography to monitor the effect of dexamethasone on non-small cell lung cancer.
P2860
Q26830488-11A3DBBF-875F-4E65-B07B-53416598AF1FQ28083663-CA269C8A-25F1-4BCD-A060-20DB4424277EQ33432327-7F4AFBCF-1367-4BFF-B25B-D0B2B9C1AD3AQ33572258-B875636C-7FDC-4936-ABBE-9B7EA38415FDQ33778668-393F1D84-38B9-49B4-A996-4939F12DA544Q33944623-86EAAA4B-4272-4762-82FC-1B5B598EDD29Q34091240-C3FF46D4-394D-4AC6-9047-8C6CC97837DFQ35677288-FEFD758C-8914-4EE6-BA6D-2575FF419FAEQ36127123-83973E2D-7E1E-4C30-A256-9075C9BC2B69Q36261427-5479915F-EB4C-46BA-90F7-65E1B1988230Q36733474-C96D7918-6DF7-43D3-BE92-0190A5A8ABF0Q37590740-1FAF0B59-391A-472A-98DE-A573B5E334CEQ38204673-267E583F-A781-49B2-AC6A-910DB9646F6DQ38264378-5AEBB754-23D3-4988-882E-90EE812541BBQ38575758-4EA31780-C221-4EDC-952F-5008636A1B06Q38669287-112F2C3E-D5E1-467D-8258-72C7C65915E0Q38922208-C8AA3DA8-7311-49AD-B684-07AC911F3708Q42365307-64A35C02-FF22-49A7-BC2D-903D5F4B9ECAQ47811425-54BD7291-BBA3-4429-96FD-F789E6B3C41EQ48014525-9563BD89-8679-403E-BDCC-9E4EC974DA1BQ50223635-4C8E3D07-1693-484D-8CB8-247E0D7862C0Q52717613-BE7643DB-D648-4087-A04F-9B64D6F9F620Q52718193-C7344EF9-72F0-462C-82D5-E63FE6F01E6A
P2860
Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Expression of thymidylate synt ...... emic review and meta-analysis.
@ast
Expression of thymidylate synt ...... emic review and meta-analysis.
@en
type
label
Expression of thymidylate synt ...... emic review and meta-analysis.
@ast
Expression of thymidylate synt ...... emic review and meta-analysis.
@en
prefLabel
Expression of thymidylate synt ...... emic review and meta-analysis.
@ast
Expression of thymidylate synt ...... emic review and meta-analysis.
@en
P2093
P2860
P1476
Expression of thymidylate synt ...... emic review and meta-analysis.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00280-013-2299-2
P577
2013-09-26T00:00:00Z
P6179
1047137697